CHEST Guidelines-Correction-to-Byline-in--Deaths-Related-to-Bronchi (1)

Correction-to-Byline-in--Deaths-Related-to-Bronchi (1)

Pdf Summary

The provided text is an errata document from the journal CHEST, addressing corrections in previously published articles. <br /><br />Firstly, in the article "Tracheobronchopathy From Inhaled Corticosteroids" (Chest. 2017), errors were identified in Table 1. This table was supposed to guide prescribing physicians on what constitutes a “high-dose” inhaled corticosteroid, but it mistakenly suggested strict dose equivalence. Specifically, there were errors in doses for beclometasone dipropionate, budesonide, mometasone furoate, and triamcinolone acetonide. These errors have been corrected and the updated table has been integrated into the online article.<br /><br />Secondly, there was a correction related to the authorship of the article "Deaths Related to Bronchial Arterial Embolization in Patients With Cystic Fibrosis: Three Cases and an Institutional Review" (Chest. 2016). Eric J. Monroe, MD, should have been listed as the second author. This oversight has also been corrected in the online version of the article.<br /><br />The corrected Table 1 lists estimated clinical comparability doses for various inhaled corticosteroids, with specified low, medium, and high-dose categories for each. These changes are accompanied by a note indicating that the table is adapted from the Global Initiative for Asthma's 2017 strategy guide for asthma management.<br /><br />Overall, these corrections aim to enhance the clarity of dosage guidance for inhaled corticosteroids and ensure appropriate authorship recognition to maintain the integrity and accuracy of the CHEST publications.

Keywords

CHEST journal

errata document

inhaled corticosteroids

dosage correction

beclometasone dipropionate

budesonide

mometasone furoate

triamcinolone acetonide

authorship correction

asthma management